Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 45 of 98, showing 5 Applications out of 488 total, starting on record 221, ending on 225

# Protocol No Study Title Investigator(s) & Site(s)

221.

ECCT/14/02/03  
    A Phase 1/2 Randomized, Double-Blind, Dose-Finding Study to Assess the Safety, Tolerability, and Immunogenicity of Inactivated  Streptococcus pneumoniae Whole Cell Vaccine Formulated with Alum (PATH-wSP) in Healthy Kenyan Young Adults and PCV-Primed Toddlers (12-15 Months of Age)       
Principal Investigator(s)
1. Nekoye Namungu Otsyula
2. Walter Otieno
Site(s) in Kenya
Kenya Medical Research Institute (KEMRI)/Walter Reed Project, Kombewa Clinical Research Center
 
View

222.

ECCT/23/11/04   AUB Study
    A phase 1, single-center, double-blind, randomized, placebo-controlled trial to assess the safety, tolerability and initial efficacy of AHC01 delivered via transcervical catheter in adult females (25-55 years), experiencing abnormal uterine bleeding and scheduled for a hysterectomy.   
Principal Investigator(s)
1. Dr Alice Kaaria
Site(s) in Kenya
Kenyatta National Hospital (KNH)
 
View

223.

ECCT/20/06/09   HIV-CORE 006
    A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa   
Principal Investigator(s)
1. Professor Walter Jaoko, Jaoko,
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. KEMRI/ Wellcome Trust Research Programme (Kilifi county)
 
View

224.

ECCT/20/10/01   HIV-CORE 006
    A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa.    
Principal Investigator(s)
1. Eduard J Sanders
Site(s) in Kenya
1. KEMRI Mtwapa Research Clinic (Kilifi county)
2. KAVI-ICR Nairobi (Nairobi City county)
 
View

225.

ECCT/21/06/04   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted  Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Lucas Otieno
Site(s) in Kenya
1. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
2. Kenya Medical Research Institute (Kisumu county)
3. KEMRI/Walter Reed Project Research Center (Kericho county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
6. Kenya Medical Research Institute (Murang\'a county)
7. Moi University Clinical Research Centre (Uasin Gishu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Kakamega county)
 
View